KPF
CELG

K2 Principal Fund’s Celgene Corp CELG Stock Holding History

K2 Principal Fund’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50,000
Closed -$4.96M – 451
2019
Q3 		$4.96M Buy
50,000
+10,000
+25% +$950K 0.54% 57
2019
Q2 		$3.7M Buy
40,000
+5,000
+14% +$475K 0.45% 74
2019
Q1 		$3.3M Buy
+35,000
New +$3.06M 0.42% 76
2017
Q3 		– Sell
-5,265
Closed -$684K – 474
2017
Q2 		$684K Sell
5,265
-1,900
-27% -$233K 0.05% 242
2017
Q1 		$892K Sell
7,165
-635
-8% -$76K 0.07% 198
2016
Q4 		$903K Buy
+7,800
New +$869K 0.09% 170

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

K2 Principal Fund's CELG Position: Q4 2019 in Review

K2 Principal Fund sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 50,000 shares — an estimated $4.96M sold.

K2 Principal Fund first reported a position in CELG in Q4 2016 and held it in 6 quarters. The position peaked at $4.96M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • K2 Principal Fund reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • K2 Principal Fund sold 50,000 Celgene Corp shares in Q4 2019, an estimated $4.96M.
  • K2 Principal Fund first reported a position in Celgene Corp in Q4 2016 and held it in 6 quarters.
  • K2 Principal Fund's Celgene Corp position peaked at $4.96M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on K2 Principal Fund's 13F filing for Q4 2019, filed 13 Feb 2020.